trending Market Intelligence /marketintelligence/en/news-insights/trending/3csv7ryjl9qphsi-necleq2 content esgSubNav
In This List

GTx raises $25M from sale of common shares

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


GTx raises $25M from sale of common shares

GTx Inc. sold 1,501,501 common shares for gross proceeds of about $25 million.

The shares were sold pursuant to the at-the-market equity offering sales agreement with Stifel Nicolaus & Co. Inc., dated Feb. 9.

Following these sales, the Memphis, Tenn.-based biopharmaceutical company may offer and sell additional common shares of up to $25 million from time to time through Stifel.